BRIEF published on 07/29/2024 at 07:05, 3 months 23 days ago Stabilus SE Consolidates DESTACO, Boosting Revenue and Results in Q3 FY2024 Revenue Growth Stabilus SE Automotive Sector DESTACO Q3 FY2024
PRESS RELEASE published on 07/29/2024 at 07:00, 3 months 23 days ago Stabilus SE consolidates DESTACO for the first time, increasing both its revenue and result in Q3 FY2024 Stabilus SE consolidates DESTACO for the first time, increasing revenue and result in Q3 FY2024. CEO and CFO provide insights on performance and future outlook Revenue Growth Stabilus SE Intégration DESTACO Q3 FY2024
BRIEF published on 07/19/2024 at 11:29, 4 months 2 days ago Stabilus SE: Web Conference on Q3 FY2024 Results Investors Stabilus SE Web Conference Analysts Q3 Results
PRESS RELEASE published on 07/19/2024 at 11:24, 4 months 2 days ago Stabilus SE: Invitation to a web conference on Q3 FY2024 results on July 29, 2024 Stabilus SE invites investors and analysts to a web conference on July 29, 2024, to discuss Q3 FY2024 results. Details and registration available on the company's website Investors Stabilus SE Web Conference Q3 FY2024 Results Conference Details
BRIEF published on 06/12/2024 at 17:34, 5 months 8 days ago Stabilus SE: Invitation to Web Conference on Adjusted FY2024 Forecast Investor Relations Stabilus SE Web Conference FY2024 Forecast June 13, 2024
PRESS RELEASE published on 06/12/2024 at 17:29, 5 months 8 days ago Stabilus SE: Invitation to a web conference on adjusted forecast for FY2024 on June 13, 2024 Stabilus SE invites investors and analysts to a web conference on June 13, 2024, to discuss the adjusted forecast for fiscal year 2024 Investors Stabilus SE Web Conference Adjusted Forecast FY2024
BRIEF published on 06/11/2024 at 20:00, 5 months 9 days ago Stabilus SE Adjusts Forecast for Fiscal Year 2024 Revenue Forecast Stabilus SE Automotive Sector Adjusted EBIT Margin Commercial Vehicles
PRESS RELEASE published on 06/11/2024 at 19:55, 5 months 9 days ago EQS-Adhoc: Stabilus SE: Adjustment of forecast for the current fiscal year 2024 Stabilus SE adjusts its forecast for fiscal year 2024 due to challenging market conditions, expecting revenues of €1.3-1.35 billion and adjusted EBIT margin of 11.7%-12.3% Market Environment Stabilus SE Forecast Adjustment Fiscal Year 2024 Revenue Expectations
BRIEF published on 05/08/2024 at 07:05, 6 months 13 days ago Stabilus SE Reports Modest Revenue Growth in Q2 FY2024 Amid Market Challenges Revenue Growth Market Challenges Stabilus SE DESTACO Acquisition Q2 FY2024 Financial Results
PRESS RELEASE published on 05/08/2024 at 07:00, 6 months 13 days ago Stabilus SE closes Q2 FY2024 with a slight increase in revenue Stabilus SE closes Q2 FY2024 with 0.9% revenue growth to €313.5 million. Acquisition of DESTACO completed, APAC region drives growth Revenue Growth Stabilus SE APAC Region DESTACO Acquisition Q2 FY2024
Published on 11/21/2024 at 13:30, 26 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 26 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 56 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 56 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 56 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 20 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 41 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 58 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 36 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 11 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 11 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
